Literature DB >> 23202699

A pathophysiology-based approach to the management of early priapism.

Jason R Kovac1, Siu K Mak, Maurice M Garcia, Tom F Lue.   

Abstract

Priapism is a rare condition that involves persistent penile erection for greater than 4 h. Distinct variants exist, each with unique characteristics. Ischemic priapism is a painful medical emergency that may occur as a result of veno-occlusion leading to hypoxia and tissue death. Recurrent bouts of ischemic priapism, or stuttering priapism, require treatment for individual attacks as well as long-term prevention. Non-ischemic priapism is associated with trauma and may be managed conservatively. Recent advances into the pathophysiology of priapism have allowed the development of treatment algorithms that specifically target the mechanisms involved. In this review, we outline the basics of smooth muscle contraction and describe how derangement of these pathways results in priapism. A pathophysiological approach to the treatment of priapism is proposed with duration-based algorithms presented to assist in management.

Entities:  

Mesh:

Year:  2012        PMID: 23202699      PMCID: PMC3739130          DOI: 10.1038/aja.2012.83

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  70 in total

1.  The management of low-flow priapism with the immediate insertion of a penile prosthesis.

Authors:  R W Rees; J Kalsi; S Minhas; J Peters; P Kell; D J Ralph
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

2.  Treatment of recurrent idiopathic priapism with oral baclofen.

Authors:  Keith F Rourke; Adam H Fischler; Gerald H Jordan
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

3.  Sildenafil relieves priapism in patients with sickle cell disease.

Authors:  Eldad S Bialecki; Kenneth R Bridges
Journal:  Am J Med       Date:  2002-08-15       Impact factor: 4.965

Review 4.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.

Authors:  Y Fukata; M Amano; K Kaibuchi
Journal:  Trends Pharmacol Sci       Date:  2001-01       Impact factor: 14.819

5.  Prevalence of priapism in children and adolescents with sickle cell anemia.

Authors:  E Mantadakis; J D Cavender; Z R Rogers; D H Ewalt; G R Buchanan
Journal:  J Pediatr Hematol Oncol       Date:  1999 Nov-Dec       Impact factor: 1.289

6.  Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells.

Authors:  A E Beltrán; F Concepción; D Manzanares; G Garrido; L A Glaria; A Rojas
Journal:  Arch Med Res       Date:  1999 Mar-Apr       Impact factor: 2.235

7.  Incidence of priapism in the general population.

Authors:  I A Eland; J van der Lei; B H Stricker; M J Sturkenboom
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

8.  The prediction of papaverine induced priapism by color Doppler sonography.

Authors:  M Secil; D Arslan; A Y Goktay; A A Esen; O Dicle; T Pirnar
Journal:  J Urol       Date:  2001-02       Impact factor: 7.450

9.  Management strategy for arterial priapism: therapeutic dilemmas.

Authors:  Dimitrios Hatzichristou; Georgios Salpiggidis; Konstantinos Hatzimouratidis; Apostolos Apostolidis; Vasilios Tzortzis; Athanasios Bekos; Dimitrios Saripoulos
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

10.  RhoA-mediated Ca2+ sensitization in erectile function.

Authors:  Hua Wang; Masumi Eto; William D Steers; Andrew P Somlyo; Avril V Somlyo
Journal:  J Biol Chem       Date:  2002-06-11       Impact factor: 5.157

View more
  20 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model.

Authors:  Fikret Erdemir; Fatih Firat; Fatma Markoc; Dogan Atilgan; Bekir Suha Parlaktas; Yunus Emre Kuyucu; Yusuf Gencten
Journal:  Int Urol Nephrol       Date:  2014-07-16       Impact factor: 2.370

3.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

4.  Surgeries in andrology: optimization and patients' well being.

Authors:  Tom F Lue; Marc Goldstein
Journal:  Asian J Androl       Date:  2012-12-17       Impact factor: 3.285

5.  Sexual dysfunction: First EAU priapism treatment guidelines published.

Authors:  Maarten Albersen; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-01-28       Impact factor: 14.432

6.  Priapism Impact Profile Questionnaire: Development and Initial Validation.

Authors:  Arthur L Burnett; Uzoma A Anele; Leonard R Derogatis
Journal:  Urology       Date:  2015-04-08       Impact factor: 2.649

7.  Hypoxia-enhanced adhesion of red blood cells in microscale flow.

Authors:  Myeongseop Kim; Yunus Alapan; Anima Adhikari; Jane A Little; Umut A Gurkan
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

8.  Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-01-09       Impact factor: 3.802

9.  The effects of combined free radical scavenger and sildenafil therapy on age-associated erectile dysfunction: An animal model.

Authors:  Jason R Kovac; Ling DeYoung; Kyle J Lehmann; Eric Chung; Gerald B Brock
Journal:  Urol Ann       Date:  2014-10

10.  Priapism and clozapine use in a patient with hypochondriacal delusional syndrome.

Authors:  Fabrício Donizete da Costa; Karina Toledo da Silva Antonialli; Paulo Dalgalarrondo
Journal:  Oxf Med Case Reports       Date:  2015-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.